High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry

Volumn 61, Issue 4, 1996, Pages 418-

  Nos, C ^a   Comabella, M ^a   Tintore M ^a   Rio, J ^a   Codina, A ^a   Montalban, X ^a   Rovira, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE;

BLOOD BRAIN BARRIER; DOSE RESPONSE; DRUG EFFECT; HUMAN; LETTER; MULTIPLE SCLEROSIS; RECURRENT DISEASE;

ANTI-INFLAMMATORY AGENTS; BLOOD-BRAIN BARRIER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; RECURRENCE;

EID: 0030265999     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.4.418-a     Document Type: Letter

References (0)